curis inc (CRIS:NASDAQ GM)
Executive Profile*
Daniel R. Passeri MSc., J.D.Chief Executive Officer and Director, Curis, Inc. |
| Age | Total Calculated Compensation | This person is connected to 9 board members in 1 different organizations across 1 different industries. See Board Relationships |
| 51 | $1,806,555 As of Fiscal Year 2012 |
Background*
Mr. Daniel R. Passeri, MSc., J.D., has been the Chief Executive Officer of Curis, Inc. since September 2001 and served as its President from September 2001 to February 2013. Mr. Passeri served as Senior Vice President, Corporate Development and Strategic Planning of Curis Inc., from November 2000 to September 2001. From March 1997 to November 2000, he was employed by GeneLogic Inc., a biotechnology company, as Senior Vice President, Corporate Development and Strategic ...
Corporate Headquarters*4 Maguire RoadLexington, Massachusetts 02421 United States Phone: 617-503-6500 Fax: 617-503-6501 Board Members Memberships*2001-Present Chief Executive Officer and Director
Education*BS Northeastern University Unknown/Other Education George Washington University Law Center JD George Washington University Law Center MS University Of London JD Imperial College MS Imperial College
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| CRIS:US | $3.83 USD | +0.05 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| James A. Bianco M.D. | Principal Founder, Chief Executive Officer, President and Executive Director Cell Therapeutics, Inc. | $1.2M |
| Robert I. Blum | Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern Cytokinetics, Incorporated | $555.0K |
| Cynthia L. Sullivan | Chief Executive Officer, President, Director and President of IBC Pharmaceuticals Inc Immunomedics Inc. | $580.6K |
| Mark Jerome Pykett V.M.D., Ph.D., MBA | Chief Executive Officer and Director Navidea Biopharmaceuticals, Inc | $425.0K |
| Scott Daniel Cormack | Founder, Chief Executive Officer, President, Treasurer, Secretary and Director OncoGenex Pharmaceuticals, Inc. | $520.4K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
Sponsored Financial Commentaries
Sponsored Links
To contact CURIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
